Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Carcinoma, Lobular × Goserelin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 12 Breast Neoplasms 11 Salivary Gland Neoplasms 1 Radiation Injuries 1 Prostate Adenocarcinoma 1 PSA Level Greater Than Two 1 Neoplasm Metastasis 1 Hormone Sensitive Prostate Cancer 1 Castration-resistant Prostate Cancer Patients with Oligometastases 1 Castrate Sensitive Prostate Cancer 1 Carcinoma, Lobular 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Neoplasms, Male 1

Interventions

Letrozole 2 palbociclib 1 entrectinib 1 Tamoxifen 1 Radiotherapy 1 Goserelin 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04551495 2024-12-04

ROSALINE

Jules Bordet Institute

Phase 2 Active not recruiting

Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡